-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
10.3322/canjclin.55.2.74, 15761078
-
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
34250020201
-
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
-
10.1053/j.gastro.2007.04.061, 17570226
-
El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576. 10.1053/j.gastro.2007.04.061, 17570226.
-
(2007)
Gastroenterology
, vol.132
, pp. 2557-2576
-
-
El-Serag, H.B.1
Rudolph, K.L.2
-
3
-
-
63049133092
-
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
-
10.1200/JCO.2008.20.7753, 2668555, 19224838
-
Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009, 27:1485-1491. 10.1200/JCO.2008.20.7753, 2668555, 19224838.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1485-1491
-
-
Altekruse, S.F.1
McGlynn, K.A.2
Reichman, M.E.3
-
4
-
-
67650874081
-
Cancer statistics, 2009
-
10.3322/caac.20006, 19474385
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249. 10.3322/caac.20006, 19474385.
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
5
-
-
0141491273
-
Hepatocellular carcinoma
-
10.1016/S0140-6736(03)14964-1, 14667750
-
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917. 10.1016/S0140-6736(03)14964-1, 14667750.
-
(2003)
Lancet
, vol.362
, pp. 1907-1917
-
-
Llovet, J.M.1
Burroughs, A.2
Bruix, J.3
-
6
-
-
58749107000
-
Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection
-
10.1097/SLA.0b013e3181904988, 19106686
-
Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg 2009, 249:118-123. 10.1097/SLA.0b013e3181904988, 19106686.
-
(2009)
Ann Surg
, vol.249
, pp. 118-123
-
-
Yang, L.Y.1
Fang, F.2
Ou, D.P.3
Wu, W.4
Zeng, Z.J.5
Wu, F.6
-
7
-
-
70449382145
-
Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation
-
10.1097/SLA.0b013e3181bd582b, 19801927
-
Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, Decaens T, Hurtova M, Memeo R, Mallat A, Duvoux C. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 2009, 250:738-746. 10.1097/SLA.0b013e3181bd582b, 19801927.
-
(2009)
Ann Surg
, vol.250
, pp. 738-746
-
-
Cherqui, D.1
Laurent, A.2
Mocellin, N.3
Tayar, C.4
Luciani, A.5
Van Nhieu, J.T.6
Decaens, T.7
Hurtova, M.8
Memeo, R.9
Mallat, A.10
Duvoux, C.11
-
8
-
-
58149376548
-
Molecular mechanisms of hepatocellular carcinoma
-
10.1002/hep.22580, 19003900
-
Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008, 48:2047-2063. 10.1002/hep.22580, 19003900.
-
(2008)
Hepatology
, vol.48
, pp. 2047-2063
-
-
Aravalli, R.N.1
Steer, C.J.2
Cressman, E.N.3
-
9
-
-
75349084543
-
Risk of HCC: genetic heterogeneity and complex genetics
-
10.1016/j.jhep.2009.11.015, 20022654
-
Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol 2010, 52:252-257. 10.1016/j.jhep.2009.11.015, 20022654.
-
(2010)
J Hepatol
, vol.52
, pp. 252-257
-
-
Dragani, T.A.1
-
10
-
-
64249135764
-
Novel agents on the horizon for cancer therapy
-
10.3322/caac.20003, 19278961
-
Ma WW, Adjei AA. Novel agents on the horizon for cancer therapy. CA Cancer J Clin 2009, 59:111-137. 10.3322/caac.20003, 19278961.
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 111-137
-
-
Ma, W.W.1
Adjei, A.A.2
-
11
-
-
54449083925
-
Molecular targeted therapies in hepatocellular carcinoma
-
10.1002/hep.22506, 2597642, 18821591
-
Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008, 48:1312-1327. 10.1002/hep.22506, 2597642, 18821591.
-
(2008)
Hepatology
, vol.48
, pp. 1312-1327
-
-
Llovet, J.M.1
Bruix, J.2
-
12
-
-
57349087153
-
Pivotal role of mTOR signaling in hepatocellular carcinoma
-
1983 e1971-1911, 10.1053/j.gastro.2008.08.008, 2678688, 18929564
-
Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL, Llovet JM. Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 2008, 135:1972-1983. 1983 e1971-1911, 10.1053/j.gastro.2008.08.008, 2678688, 18929564.
-
(2008)
Gastroenterology
, vol.135
, pp. 1972-1983
-
-
Villanueva, A.1
Chiang, D.Y.2
Newell, P.3
Peix, J.4
Thung, S.5
Alsinet, C.6
Tovar, V.7
Roayaie, S.8
Minguez, B.9
Sole, M.10
Battiston, C.11
Van Laarhoven, S.12
Fiel, M.I.13
Di Feo, A.14
Hoshida, Y.15
Yea, S.16
Toffanin, S.17
Ramos, A.18
Martignetti, J.A.19
Mazzaferro, V.20
Bruix, J.21
Waxman, S.22
Schwartz, M.23
Meyerson, M.24
Friedman, S.L.25
Llovet, J.M.26
more..
-
13
-
-
33746808398
-
Wnt/beta-catenin signaling in development and disease
-
10.1016/j.cell.2006.10.018, 17081971
-
Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480. 10.1016/j.cell.2006.10.018, 17081971.
-
(2006)
Cell
, vol.127
, pp. 469-480
-
-
Clevers, H.1
-
14
-
-
70349329537
-
Crosstalk in Met receptor oncogenesis
-
10.1016/j.tcb.2009.07.002, 19758803
-
Lai AZ, Abella JV, Park M. Crosstalk in Met receptor oncogenesis. Trends Cell Biol 2009, 19:542-551. 10.1016/j.tcb.2009.07.002, 19758803.
-
(2009)
Trends Cell Biol
, vol.19
, pp. 542-551
-
-
Lai, A.Z.1
Abella, J.V.2
Park, M.3
-
15
-
-
69149108735
-
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer
-
10.1073/pnas.0810402106, 2722321, 19617568
-
Ponzo MG, Lesurf R, Petkiewicz S, O'Malley FP, Pinnaduwage D, Andrulis IL, Bull SB, Chughtai N, Zuo D, Souleimanova M, Germain D, Omeroglu A, Cardiff RD, Hallett M, Park M. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc Natl Acad Sci USA 2009, 106:12903-12908. 10.1073/pnas.0810402106, 2722321, 19617568.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 12903-12908
-
-
Ponzo, M.G.1
Lesurf, R.2
Petkiewicz, S.3
O'Malley, F.P.4
Pinnaduwage, D.5
Andrulis, I.L.6
Bull, S.B.7
Chughtai, N.8
Zuo, D.9
Souleimanova, M.10
Germain, D.11
Omeroglu, A.12
Cardiff, R.D.13
Hallett, M.14
Park, M.15
-
16
-
-
63849163410
-
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients
-
10.1200/JCO.2008.19.1635, 19255323
-
Cappuzzo F, Marchetti A, Skokan M, Rossi E, Gajapathy S, Felicioni L, Del Grammastro M, Sciarrotta MG, Buttitta F, Incarbone M, Toschi L, Finocchiaro G, Destro A, Terracciano L, Roncalli M, Alloisio M, Santoro A, Varella-Garcia M. Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. J Clin Oncol 2009, 27:1667-1674. 10.1200/JCO.2008.19.1635, 19255323.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1667-1674
-
-
Cappuzzo, F.1
Marchetti, A.2
Skokan, M.3
Rossi, E.4
Gajapathy, S.5
Felicioni, L.6
Del Grammastro, M.7
Sciarrotta, M.G.8
Buttitta, F.9
Incarbone, M.10
Toschi, L.11
Finocchiaro, G.12
Destro, A.13
Terracciano, L.14
Roncalli, M.15
Alloisio, M.16
Santoro, A.17
Varella-Garcia, M.18
-
17
-
-
33745220780
-
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype
-
10.1172/JCI27236, 1462944, 16710476
-
Kaposi-Novak P, Lee JS, Gomez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 2006, 116:1582-1595. 10.1172/JCI27236, 1462944, 16710476.
-
(2006)
J Clin Invest
, vol.116
, pp. 1582-1595
-
-
Kaposi-Novak, P.1
Lee, J.S.2
Gomez-Quiroz, L.3
Coulouarn, C.4
Factor, V.M.5
Thorgeirsson, S.S.6
-
18
-
-
73449111266
-
Developing c-MET pathway inhibitors for cancer therapy: progress and challenges
-
10.1016/j.molmed.2009.11.005, 20031486
-
Liu X, Newton RC, Scherle PA. Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. Trends Mol Med 2010, 16:37-45. 10.1016/j.molmed.2009.11.005, 20031486.
-
(2010)
Trends Mol Med
, vol.16
, pp. 37-45
-
-
Liu, X.1
Newton, R.C.2
Scherle, P.A.3
-
19
-
-
34249075147
-
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
-
10.1126/science.1141478, 17463250
-
Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Janne PA. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007, 316:1039-1043. 10.1126/science.1141478, 17463250.
-
(2007)
Science
, vol.316
, pp. 1039-1043
-
-
Engelman, J.A.1
Zejnullahu, K.2
Mitsudomi, T.3
Song, Y.4
Hyland, C.5
Park, J.O.6
Lindeman, N.7
Gale, C.M.8
Zhao, X.9
Christensen, J.10
Kosaka, T.11
Holmes, A.J.12
Rogers, A.M.13
Cappuzzo, F.14
Mok, T.15
Lee, C.16
Johnson, B.E.17
Cantley, L.C.18
Janne, P.A.19
-
20
-
-
67649497434
-
Predictors of survival after resection of early hepatocellular carcinoma
-
10.1097/SLA.0b013e3181a38eb5, 19387322
-
Nathan H, Schulick RD, Choti MA, Pawlik TM. Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 2009, 249:799-805. 10.1097/SLA.0b013e3181a38eb5, 19387322.
-
(2009)
Ann Surg
, vol.249
, pp. 799-805
-
-
Nathan, H.1
Schulick, R.D.2
Choti, M.A.3
Pawlik, T.M.4
-
21
-
-
39749083508
-
Prediction of microvascular invasion before curative resection of hepatocellular carcinoma
-
10.1002/jso.20953, 18095300
-
Kim BK, Han KH, Park YN, Park MS, Kim KS, Choi JS, Moon BS, Chon CY, Moon YM, Ahn SH. Prediction of microvascular invasion before curative resection of hepatocellular carcinoma. J Surg Oncol 2008, 97:246-252. 10.1002/jso.20953, 18095300.
-
(2008)
J Surg Oncol
, vol.97
, pp. 246-252
-
-
Kim, B.K.1
Han, K.H.2
Park, Y.N.3
Park, M.S.4
Kim, K.S.5
Choi, J.S.6
Moon, B.S.7
Chon, C.Y.8
Moon, Y.M.9
Ahn, S.H.10
-
22
-
-
58149352266
-
MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis
-
10.1038/nm.1889, 19098908
-
Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W, Schlag PM. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009, 15:59-67. 10.1038/nm.1889, 19098908.
-
(2009)
Nat Med
, vol.15
, pp. 59-67
-
-
Stein, U.1
Walther, W.2
Arlt, F.3
Schwabe, H.4
Smith, J.5
Fichtner, I.6
Birchmeier, W.7
Schlag, P.M.8
-
24
-
-
33845957252
-
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial
-
10.1097/01.sla.0000231758.07868.71, 1867934, 17197963
-
Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, Zhang CQ, Lau WY, Li JQ. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 2007, 245:36-43. 10.1097/01.sla.0000231758.07868.71, 1867934, 17197963.
-
(2007)
Ann Surg
, vol.245
, pp. 36-43
-
-
Shi, M.1
Guo, R.P.2
Lin, X.J.3
Zhang, Y.Q.4
Chen, M.S.5
Zhang, C.Q.6
Lau, W.Y.7
Li, J.Q.8
-
25
-
-
39049192533
-
Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population
-
10.1158/1078-0432.CCR-05-2261, 16857788
-
Tang SH, Yang DH, Huang W, Zhou HK, Lu XH, Ye G. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population. Clin Cancer Res 2006, 12:4171-4177. 10.1158/1078-0432.CCR-05-2261, 16857788.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 4171-4177
-
-
Tang, S.H.1
Yang, D.H.2
Huang, W.3
Zhou, H.K.4
Lu, X.H.5
Ye, G.6
-
26
-
-
79955860688
-
Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy
-
10.1016/j.clinbiochem.2011.02.012, 21376027
-
Huang P, Qiu J, Li B, Hong J, Lu C, Wang L, Wang J, Hu Y, Jia W, Yuan Y. Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. Clin Biochem 2011, 44:582-589. 10.1016/j.clinbiochem.2011.02.012, 21376027.
-
(2011)
Clin Biochem
, vol.44
, pp. 582-589
-
-
Huang, P.1
Qiu, J.2
Li, B.3
Hong, J.4
Lu, C.5
Wang, L.6
Wang, J.7
Hu, Y.8
Jia, W.9
Yuan, Y.10
-
27
-
-
44949231424
-
Analyzing real-time PCR data by the comparative C(T) method
-
10.1038/nprot.2008.73, 18546601
-
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108. 10.1038/nprot.2008.73, 18546601.
-
(2008)
Nat Protoc
, vol.3
, pp. 1101-1108
-
-
Schmittgen, T.D.1
Livak, K.J.2
-
28
-
-
0037470276
-
Methods for categorizing a prognostic variable in a multivariable setting
-
10.1002/sim.1333, 12590414
-
Mazumdar M, Smith A, Bacik J. Methods for categorizing a prognostic variable in a multivariable setting. Stat Med 2003, 22:559-571. 10.1002/sim.1333, 12590414.
-
(2003)
Stat Med
, vol.22
, pp. 559-571
-
-
Mazumdar, M.1
Smith, A.2
Bacik, J.3
-
29
-
-
79956115936
-
MACC 1 as a marker for vascular invasive hepatocellular carcinoma
-
Shirahata A, Fan W, Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K. MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res 2011, 31:777-780.
-
(2011)
Anticancer Res
, vol.31
, pp. 777-780
-
-
Shirahata, A.1
Fan, W.2
Sakuraba, K.3
Yokomizo, K.4
Goto, T.5
Mizukami, H.6
Saito, M.7
Ishibashi, K.8
Kigawa, G.9
Nemoto, H.10
Sanada, Y.11
Hibi, K.12
-
30
-
-
4544301860
-
High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations
-
10.1002/ijc.20279, 15305374
-
Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer 2004, 112:44-50. 10.1002/ijc.20279, 15305374.
-
(2004)
Int J Cancer
, vol.112
, pp. 44-50
-
-
Peng, S.Y.1
Chen, W.J.2
Lai, P.L.3
Jeng, Y.M.4
Sheu, J.C.5
Hsu, H.C.6
-
31
-
-
0033845583
-
Extrahepatic metastases of hepatocellular carcinoma
-
Katyal S, Oliver JH, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000, 216:698-703.
-
(2000)
Radiology
, vol.216
, pp. 698-703
-
-
Katyal, S.1
Oliver, J.H.2
Peterson, M.S.3
Ferris, J.V.4
Carr, B.S.5
Baron, R.L.6
-
32
-
-
17544380855
-
Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves
-
10.1001/archsurg.135.12.1456, 11115352
-
Sakon M, Umeshita K, Nagano H, Eguchi H, Kishimoto S, Miyamoto A, Ohshima S, Dono K, Nakamori S, Gotoh M, Monden M. Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves. Arch Surg 2000, 135:1456-1459. 10.1001/archsurg.135.12.1456, 11115352.
-
(2000)
Arch Surg
, vol.135
, pp. 1456-1459
-
-
Sakon, M.1
Umeshita, K.2
Nagano, H.3
Eguchi, H.4
Kishimoto, S.5
Miyamoto, A.6
Ohshima, S.7
Dono, K.8
Nakamori, S.9
Gotoh, M.10
Monden, M.11
-
33
-
-
58149504413
-
Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study
-
10.1016/j.ejso.2008.01.027, 18325724
-
Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study. Eur J Surg Oncol 2009, 35:174-179. 10.1016/j.ejso.2008.01.027, 18325724.
-
(2009)
Eur J Surg Oncol
, vol.35
, pp. 174-179
-
-
Kawano, Y.1
Sasaki, A.2
Kai, S.3
Endo, Y.4
Iwaki, K.5
Uchida, H.6
Shibata, K.7
Ohta, M.8
Kitano, S.9
-
34
-
-
68449099009
-
MACC1 controls Met: what a difference an Sp1 site makes
-
10.4161/cc.8.15.9018, 19556890
-
Stein U, Smith J, Walther W, Arlt F. MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle 2009, 8:2467-2469. 10.4161/cc.8.15.9018, 19556890.
-
(2009)
Cell Cycle
, vol.8
, pp. 2467-2469
-
-
Stein, U.1
Smith, J.2
Walther, W.3
Arlt, F.4
-
35
-
-
70350337085
-
Colon cancer metastasis: MACC1 and Met as metastatic pacemakers
-
10.1016/j.biocel.2009.08.001, 19666136
-
Arlt F, Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 2009, 41:2356-2359. 10.1016/j.biocel.2009.08.001, 19666136.
-
(2009)
Int J Biochem Cell Biol
, vol.41
, pp. 2356-2359
-
-
Arlt, F.1
Stein, U.2
-
36
-
-
75749153594
-
MACC1 - more than metastasis? Facts and predictions about a novel gene
-
10.1007/s00109-009-0537-1, 19787327
-
Stein U, Dahlmann M, Walther W. MACC1 - more than metastasis? Facts and predictions about a novel gene. J Mol Med 2010, 88:11-18. 10.1007/s00109-009-0537-1, 19787327.
-
(2010)
J Mol Med
, vol.88
, pp. 11-18
-
-
Stein, U.1
Dahlmann, M.2
Walther, W.3
-
37
-
-
75449104452
-
Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry
-
Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW, Che N, Wang XH, Du J, Liu YX, Sun BC. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology 2010, 51:545-556.
-
(2010)
Hepatology
, vol.51
, pp. 545-556
-
-
Sun, T.1
Zhao, N.2
Zhao, X.L.3
Gu, Q.4
Zhang, S.W.5
Che, N.6
Wang, X.H.7
Du, J.8
Liu, Y.X.9
Sun, B.C.10
-
38
-
-
0032898742
-
Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization
-
10.1002/hep.510290410, 10094966
-
Zimonjic DB, Keck CL, Thorgeirsson SS, Popescu NC. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology 1999, 29:1208-1214. 10.1002/hep.510290410, 10094966.
-
(1999)
Hepatology
, vol.29
, pp. 1208-1214
-
-
Zimonjic, D.B.1
Keck, C.L.2
Thorgeirsson, S.S.3
Popescu, N.C.4
-
39
-
-
66349107985
-
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC
-
10.1136/gut.2008.152652, 19136513
-
Calvisi DF, Pinna F, Ladu S, Pellegrino R, Simile MM, Frau M, De Miglio MR, Tomasi ML, Sanna V, Muroni MR, Feo F, Pascale RM. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut 2009, 58:679-687. 10.1136/gut.2008.152652, 19136513.
-
(2009)
Gut
, vol.58
, pp. 679-687
-
-
Calvisi, D.F.1
Pinna, F.2
Ladu, S.3
Pellegrino, R.4
Simile, M.M.5
Frau, M.6
De Miglio, M.R.7
Tomasi, M.L.8
Sanna, V.9
Muroni, M.R.10
Feo, F.11
Pascale, R.M.12
-
40
-
-
0032742269
-
New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis
-
10.1038/sj.bjc.6690769, 2374300, 10555751
-
Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer 1999, 81:814-821. 10.1038/sj.bjc.6690769, 2374300, 10555751.
-
(1999)
Br J Cancer
, vol.81
, pp. 814-821
-
-
Tian, J.1
Tang, Z.Y.2
Ye, S.L.3
Liu, Y.K.4
Lin, Z.Y.5
Chen, J.6
Xue, Q.7
-
41
-
-
39549099942
-
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis
-
Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, Kleeff J, Ehemann V, Eils R, Lichter P, Schirmacher P, Radlwimmer B. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 2008, 47:511-520.
-
(2008)
Hepatology
, vol.47
, pp. 511-520
-
-
Schlaeger, C.1
Longerich, T.2
Schiller, C.3
Bewerunge, P.4
Mehrabi, A.5
Toedt, G.6
Kleeff, J.7
Ehemann, V.8
Eils, R.9
Lichter, P.10
Schirmacher, P.11
Radlwimmer, B.12
|